Biomaterials Research (생체재료학회지)

Korean Society for Biomaterials (한국생체재료학회)
권호 표지

The Market Analysis of Polymeric Biomaterials for Biomedical Applications

고분자 생체재료의 시장동향 분석과 전망

  • Eo, Jin Won (Technology Commercialization Intelligence Center, Korea Institute of Science and Technology Information(KISTI)) ;
  • Hahn, Hyuk (Technology Commercialization Intelligence Center, Korea Institute of Science and Technology Information(KISTI)) ;
  • Seo, Ju Hwan (Technology Commercialization Intelligence Center, Korea Institute of Science and Technology Information(KISTI)) ;
  • Lee, Joon Woo (Technology Commercialization Intelligence Center, Korea Institute of Science and Technology Information(KISTI))
  • 어진원 (한국과학기술정보연구원 TCI센터) ;
  • 한혁 (한국과학기술정보연구원 TCI센터) ;
  • 서주환 (한국과학기술정보연구원 TCI센터) ;
  • 이준우 (한국과학기술정보연구원 TCI센터)
  • Published : 2012.09.01
⟨ Previous Next ⟩

Abstract

Polymeric biomaterials have been used for various biomedical applications for several decades. Of these polymers, the application of PLA(poly(lactic acid)), PGA(poly(glycolic acid)), and their copolymers has received a great deal of attention in the past 15 years for use in controlled drug delivery systems, tissue repair, tissue engineering, and controlling certain biological events. Interest in synthetic absorbable polymers has grown considerably over the last three decades, principally because of their transient nature when used as biochemical implants or drug carriers. The global market of polymeric biomaterials is expected to amount to $ 2.8 billion in 2012 and $ 4.6 billion in 2015. We focused on the recent progress in R&D and analyzed the recent market trend related to polymeric biomaterials.

Keywords

References

  1. Dae Hyeon Lim, et. al., "The market analysis and perspectives of bioplastics," Biomaterials Research., 15(2), 66-71 (2011).
  2. Markets and markets, "Global Lactic Acid & Poly Lactic Acid(PLA) Market by Raw Materials, Types, Applications and Potential Opportunities (Forecast to 2016) (2011).
  3. The Freedonia Group, Inc., "World Bioplastics," Industry Study 2548, 2009.
  4. SRI Consulting Business Intelligence, Explore, Biopolymers, 2005.
  5. X. Wang, et. al. "Tissue engineering of biphasic cartilage constructs using various biodegradable scaffolds: an in vitro study," Biomaterials., 25, 3681-3688 (2004). https://doi.org/10.1016/j.biomaterials.2003.10.102
  6. E. Marshall, "The business of stem cells," Science., 287, 1419-1421 (2000). https://doi.org/10.1126/science.287.5457.1419
  7. J. A. Thomson, et. al., "Embryonic stem cell lines derived from human blastocysts," Science., 282, 1145-1147 (1998). https://doi.org/10.1126/science.282.5391.1145
  8. H. Alexander, "The clinical impact of tissue engineering," Tissue Engineering., 1, 197-202 (1995). https://doi.org/10.1089/ten.1995.1.197
  9. R. Langer and J. P. Vacanti, "Tissue Engineering," Science., 260, 920-926 (1993). https://doi.org/10.1126/science.8493529